News
- Author:
- Nancy A. Melville
Publish date: April 17, 2023
“Clinicians should be aware that even minor weight loss of 5% or more in older adults without life-limiting illnesses can increase mortality risk.”...
News
- Author:
- Nancy A. Melville
Publish date: March 29, 2023
“This is an important study confirming that breast conservation is feasible and safe for women with multiple ipsilateral breast cancers, with excel...
News
- Author:
- Nancy A. Melville
Publish date: March 14, 2023
The American Academy of Sleep Medicine recommends CBT-I as first-line treatment for insomnia, with the key benefit being its exemplary safety profi...
News
- Author:
- Nancy A. Melville
Publish date: March 14, 2023
Overall, 48% of participants achieved a response, and 24% achieved remission of depressive symptoms following the first 4 weeks of twice-weekly tre...
News
- Author:
- Nancy A. Melville
Publish date: March 14, 2023
“These results are of great impact for clinicians managing older adults with treatment-resistant depression,” said Dr. Jennifer Gatchel.
News
- Author:
- Nancy A. Melville
Publish date: March 10, 2023
Brexpiprazole will become the first drug to be approved for agitation in AD, doctor speculates.
News
- Author:
- Nancy A. Melville
Publish date: February 24, 2023
“Instead of having the burden of taking a pill every day, patients with HIV can now have these choices of being able to forget about their treatmen...
News
- Author:
- Nancy A. Melville
Publish date: February 24, 2023
Women are known to be at higher risk of infection because the lining of the vagina is thinner than the skin of the penis, allowing for easier penet...
News
- Author:
- Nancy A. Melville
Publish date: February 22, 2023
“The duration of protective efficacy – a big thing in vaccines – is unknown. Still, this is really significant.”
News
- Author:
- Nancy A. Melville
Publish date: February 21, 2023
“Clinicians will not feel comfortable with the short regimens at this point, but it is remarkable that so many patients did well with shorter treat...
News
- Author:
- Nancy A. Melville
Publish date: February 17, 2023
New study showed similar survival rates among AML patients treated solely with consolidation chemotherapy and those who received allogenic HCT.
News
- Author:
- Nancy A. Melville
Publish date: February 15, 2023
Compared with older women with early stage HR-positive breast cancer, women under 40 years of age had significantly higher frequencies of certain m...
News
- Author:
- Nancy A. Melville
Publish date: January 30, 2023
Black women are more likely to develop more aggressive, premenopausal breast cancers, including triple-negative breast cancer, that are more easily...
News
- Author:
- Nancy A. Melville
Publish date: January 18, 2023
‘There seems to be something different happening with vitamin D metabolism at higher body weights,’ said the author of a new paper.
News
- Author:
- Nancy A. Melville
Publish date: January 9, 2023
The joint statement from the American Thyroid Association and European Thyroid Association offers appraisal of recent thyroid eye disease managemen...
